SCHEMBL20749385

SCHEMBL20749385

Cc1ccc(SNc2cc(F)c(F)c(C(=O)c3ccc4ncc(N5CCOCC5)nc4c3)c2F)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.41
HPGD P15428 2/20 0.41
LMNA P02545 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
CDK6 Q00534 3/20 0.40
CYP1A2 P05177 2/20 0.39
MAPT P10636 2/20 0.39
CYP2C19 P33261 2/20 0.39
KDM4E B2RXH2 2/20 0.39
GAA P10253 1/20 0.39
PIK3CD O00329 3/20 0.38
PIK3CA P42336 3/20 0.38
PIK3CB P42338 3/20 0.38
MTOR P42345 2/20 0.38
PIK3CG P48736 2/20 0.38
PRKDC P78527 1/20 0.38
PIK3C3 Q8NEB9 1/20 0.38
HDAC3 O15379 1/20 0.37
HDAC2 Q92769 1/20 0.37
SHMT2 P34897 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20749370 0.92 HCAR2 (0.41) ALDH1A1HPGDSMN1; SMN2CDK6PIK3CD
SCHEMBL20749378 0.85 CDK6 (0.41) HPGDCDK6PIK3CDPIK3CAPIK3CB
SCHEMBL20749358 0.85 CDK6 (0.42) HPGDCDK6PIK3CDPIK3CAPIK3CB
SCHEMBL14715939 0.85 PIK3CA (0.53) ALDH1A1HPGDLMNASMN1; SMN2CDK6
SCHEMBL14716359 0.82 CDK6 (0.42) HPGDCDK6GAAPIK3CDPIK3CA
SCHEMBL29590072 0.82 CDK6 (0.42) HPGDCDK6GAAPIK3CDPIK3CA
SCHEMBL14829458 0.80 HPGD (0.46) ALDH1A1HPGDLMNASMN1; SMN2CDK6
Uplarafenib SCHEMBL29623930 0.80 BRAF (0.51) HPGDCDK6CYP2C19PIK3CDPIK3CA
Uplarafenib SCHEMBL14716189 0.80 BRAF (0.51) HPGDCDK6CYP2C19PIK3CDPIK3CA
SCHEMBL14716129 0.79 PIK3CB (0.44) HPGDCDK6PIK3CDPIK3CAPIK3CB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2747767-B1 CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS NEUPHARMA INC (US) 2019-02-20 EP disclosed